IL4I1 and cancer: A recent study has revealed that the L-amino acid oxidase interleukin-4-induced-1 (IL4I1) generates indole metabolites and kynurenic acid, which are agonists of AHR, thereby promoting cancer cell motility and suppressing adaptive immunity.